Chitin Biology and Beyond: Chemical Biology Aiming to Enhanced Chitin Utilization and Insect Pest Control

Tamo       Fukamizo; Qing       Yang

[1] 
Jia X, Mijanur MD, Rajib R, Yin H. Recognition pattern, functional mechanism and application of chitin and chitosan oligosaccharides in sustainable agriculture. Curr Pharm Des  2020; 26(29): 3508-21.
[2] 
Ogata M. Chemoenzymatic synthesis and function of chitin derivatives. Curr Pharm Des  2020; 26(29): 3522-9.
[3] 
Muthukrishnan S, Munb S, Noh MY, Geisbrechta ER, Arakane Y. Insect cuticular chitin contributes to form and function. Curr Pharm Des  2020; 26(29): 3530-45.
[4] 
Wang Y, Gao L, Moussian B. Drosophila, chitin and insect pest management. Curr Pharm Des  2020; 26(29): 3546-53.
[5] 
Rösner J, Wellmeyer B, Merzendorfer H. Tribolium castaneum: a model for investigating the mode of action of insecticides and mechanisms of resistance. Curr Pharm Des  2020; 26(29): 3554-68.

Download Options

Rights & Permissions Print Cite

Current Pharmaceutical Design

Title:Chitin Biology and Beyond: Chemical Biology Aiming to Enhanced Chitin Utilization and Insect Pest Control

Volume: 26 Issue: 29

Author(s): Tamo Fukamizo and Qing Yang

Affiliation:

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Fukamizo Tamo and Yang Qing , Chitin Biology and Beyond: Chemical Biology Aiming to Enhanced Chitin Utilization and Insect Pest Control, Current Pharmaceutical Design 2020; 26 (29) . https://dx.doi.org/10.2174/138161282629200730113058

DOI https://dx.doi.org/10.2174/138161282629200730113058	Print ISSN 1381-6128
Publisher Name Bentham Science Publisher	Online ISSN 1873-4286

About this journal

Call for Papers in Thematic Issues

Submission closes on : 30 July, 2024

"Tuberculosis Prevention, Diagnosis and Drug Discovery"

The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more

Guest Editor(s): M Pinheiro

Submission closes on : 18 September, 2024

Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions

Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more

Guest Editor(s): Sidharth Mehan

Submission closes on : 29 September, 2024

Emerging and re-emerging diseases

Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more

Guest Editor(s): Marcos Roberto Tovani Palone

Submission closes on : 30 June, 2024

Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances

In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more

Guest Editor(s): MF Chedid